Morin as a Modulator of Hepatic Glucose Fluxes: A Balance Between Antihyperglycemic Potential and Mitochondrial Toxicity
Journal of Biochemical and Molecular Toxicology · 2025-07 · 39 (7)
DOI: 10.1002/jbt.70386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 30.06.2025. Verfasst von Letícia Fernanda Nanami und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biological Oxidations, Department of Biochemistry, State University of Maringá, Maringá, Paraná, Brazil. Hauptthemen laut MEDLINE: Flavonoids, Gluconeogenesis, Mitochondria, Liver, Glucose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by grants from the National Council for Scientific and Technological Development (CNPq), the Araucaria Foundation (FA), and the Coordinat….
Abstract (Originalsprache)
This study evaluated the acute effects of morin on gluconeogenesis and glycogenolysis, key metabolic pathways that maintain glycemia, in perfused rat livers. It also assessed the acute effects of morin on mitochondrial energy metabolism and toxicity in hepatic cancer cells (HepG2) and renal epithelial cells (VERO), alongside its impact on the activity of key enzymes. Liver perfusion experiments assessed glucose fluxes, oxygen consumption, adenine nucleotide levels, and enzyme activities. Isolated mitochondria evaluated the effects of morin on oxidative phosphorylation. Enzymatic assays and MTT tests conducted in vitro determined the effects on hepatic enzymes and cell viability. In perfused rat livers, morin generally inhibited gluconeogenesis from various substrates, stimulated glycogenolysis and glycolysis, and altered oxygen consumption. Experiments on morin biotransformation suggested that this process may contribute to the inhibition of gluconeogenesis. Moreover, morin inhibited citric acid cycle activity under gluconeogenic conditions and reduced cellular ATP/ADP and ATP/AMP ratios under both gluconeogenic and glycogenolytic conditions. The elevated activity of cytosolic and mitochondrial enzymes in the effluent from perfused livers indicated impaired membrane integrity. In isolated rat liver mitochondria, morin inhibited the electron transport chain, the ATP/ADP exchange system, and functioned as an uncoupling agent of oxidative phosphorylation, thereby reducing ATP synthesis. Under in vitro conditions, morin inhibited the activity of glucose 6‐phosphatase, glucokinase, glucose 6‐phosphate dehydrogenase, and pyruvate kinase from rat livers. At the cellular level, morin decreased the viability of HepG2 and VERO cells, indicating its toxicity. The increased glucose release due to heightened glycogenolysis, combined with the suppression of gluconeogenesis, may impact the expected antihyperglycemic effects of morin. These outcomes were partly attributed to mitochondrial bioenergetic disruption, which is an important consideration for the therapeutic use of morin, particularly with prolonged treatment or higher doses. Together, these findings highlight morin's potential as an antihyperglycemic agent but also reveal significant concerns regarding its mitochondrial toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biological Oxidations, Department of Biochemistry, State University of Maringá, Maringá, Paraná, Brazil.
- Laboratory of Plant Biochemistry, Department of Biochemistry, State University of Maringá, Maringá, Paraná, Brazil.
- Laboratory of Molecular Biology of Prokaryotes, Department of Biochemistry, State University of Maringá, Maringá, Paraná, Brazil.
- Laboratory of Technological Innovation in the Development of Pharmaceuticals and Cosmetics, Department of Basic Health Sciences, State University of Maringá, Maringá, Paraná, Brazil.
ORCID-Profile: Letícia Fernanda Nanami, Gabriele Sauthier Romano de Melo, Paulo Sérgio Alves Bueno, Osvaldo Ferrarese-Filho, Rogério Marchiosi, Rodrigo Polimeni Constantin
Förderung
- This study was funded by grants from the National Council for Scientific and Technological Development (CNPq), the Araucaria Foundation (FA), and the Coordinat…
Zitieren
APA
Nanami, L. F., Klosowski, E. M., Mito, M. S., Esquissato, G. N. M., Viana, G. A., Abido, A. C. O., Silva, M. C. D., Mendonça, A. P. D. S., de Melo, G. S. R., Bueno, P. S. A., Garcia, F. P., Bidoia, D. L., Nakamura, T. U., Nakamura, C. V., Ishii-Iwamoto, E. L., Ferro, A. P., Dos Santos, W. D., Ferrarese-Filho, O., Marchiosi, R., & Constantin, R. P. (2025). Morin as a Modulator of Hepatic Glucose Fluxes: A Balance Between Antihyperglycemic Potential and Mitochondrial Toxicity. Journal of Biochemical and Molecular Toxicology, 39(7). https://doi.org/10.1002/jbt.70386
Vancouver
Nanami LF, Klosowski EM, Mito MS, Esquissato GNM, Viana GA, Abido ACO, et al. Morin as a Modulator of Hepatic Glucose Fluxes: A Balance Between Antihyperglycemic Potential and Mitochondrial Toxicity. Journal of Biochemical and Molecular Toxicology. 2025;39(7). doi:10.1002/jbt.70386
BibTeX
@article{Nanami2025,
author = {Nanami, Letícia Fernanda and Klosowski, Eduardo Makiyama and Mito, Márcio Shigueaki and Esquissato, Giovana Natiele Machado and Viana, Gabriel Arcanjo and Abido, Ana Clara Oliveira and Silva, Mariane Carneiro da and Mendonça, Ana Paula da Silva and de Melo, Gabriele Sauthier Romano and Bueno, Paulo Sérgio Alves and Garcia, Francielle Pelegrin and Bidoia, Danielle Lazarin and Nakamura, Tânia Ueda and Nakamura, Celso Vataru and Ishii-Iwamoto, Emy Luiza and Ferro, Ana Paula and Dos Santos, Wanderley Dantas and Ferrarese-Filho, Osvaldo and Marchiosi, Rogério and Constantin, Rodrigo Polimeni},
title = {Morin as a Modulator of Hepatic Glucose Fluxes: A Balance Between Antihyperglycemic Potential and Mitochondrial Toxicity},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
volume = {39},
number = {7},
doi = {10.1002/jbt.70386}
}
EUVIMED